TSW
PMC

Thompson Siegel & Walmsley’s PharMerica Corporation PMC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-26
Closed -$1K – 928
2017
Q1 		$1K Hold
26
– – ﹤0.01% 846
2016
Q4 		$1K Buy
+26
New +$656 ﹤0.01% 868
2015
Q2 		– Sell
-536,563
Closed -$15.1M – 736
2015
Q1 		$15.1M Sell
536,563
-413,146
-44% -$10.3M 0.26% 161
2014
Q4 		$19.7M Buy
949,709
+570,153
+150% +$13.5M 0.37% 98
2014
Q3 		$9.27M Buy
379,556
+126,290
+50% +$3.35M 0.18% 197
2014
Q2 		$7.24M Buy
+253,266
New +$7.04M 0.14% 230

Other funds holding PMC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thompson Siegel & Walmsley's PMC Position: Q2 2017 in Review

Thompson Siegel & Walmsley sold out of PharMerica Corporation (PMC) in Q2 2017, closing a stake of 26 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in PMC in Q2 2014 and held it in 6 quarters. The position peaked at $19.7M in Q4 2014. 157 funds tracked by Wall St. Rank hold PMC as of Q2 2017.

  • Thompson Siegel & Walmsley reported no remaining PharMerica Corporation position as of Q2 2017 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 26 PharMerica Corporation shares in Q2 2017, an estimated $1K.
  • Thompson Siegel & Walmsley first reported a position in PharMerica Corporation in Q2 2014 and held it in 6 quarters.
  • Thompson Siegel & Walmsley's PharMerica Corporation position peaked at $19.7M in Q4 2014.
  • 157 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2017, filed 9 Aug 2017.